Affimed(AFMD) - 2023 Q4 - Earnings Call Transcript

Affimed N.V. (NASDAQ:AFMD) Q4 2023 Earnings Conference Call March 28, 2024 8:30 AM ET Company Participants Alexander Fudukidis – Head-Investor Relations Andreas Harstrick – Chief Medical Officer and Interim Acting Chief Executive Officer Michael Wolf – Vice President-Finance Conference Call Participants Srikripa Devarakonda – Truist Daina Graybosch – Leerink Partners Operator Good day, everyone, and welcome to Affimed's Fourth Quarter and Full Year 2023 Earnings and Corporate Update Call. At this time all p ...